Synthesis of GS-443902, GS-443902-13C5, and their mono-phosphates. Delivery to be 12 weeks from time of award. 2/11/2021 to 5/7/2021.
Ended Purchase Order Awarded
- Contract number
- 75N95021P00090
- Awardee
-
Adesis, Inc. UEI TYJ2UX4LW5K8 Part of Universal Display Corporation
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $93,470
Award facts
- Opportunity
-
- Off-Site Storage for Frozen Compound Management Samples and Freezers for NCATS Solicitation · 75N95021Q00051 · Posted Jan 26, 2021
- Contract value 100% obligated
- $93,470.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New Castle, DE 19720, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, valued at $93,470.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Adesis, Inc., a subsidiary of Universal Display Corporation. The contract is for the synthesis and delivery of three chemical compounds, GS-443902, GS-443902-13C5, and their mono-phosphates, within 12 weeks. This purchase order is not associated with a larger contracting vehicle and does not have a set-aside designation. The contract supports NCATS' Chemical Genomics Center, which is focused on identifying and developing novel small molecule leads for a wide range of human disease targets.
Quick answers
Who was awarded contract 75N95021P00090?
75N95021P00090 was awarded to Adesis, Inc. by National Institute on Drug Abuse (National Institutes of Health) on February 11, 2021.
How much is contract 75N95021P00090 worth?
The government has obligated $93,470 on 75N95021P00090.
Which agency awarded contract 75N95021P00090?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00090, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00090 competed?
The extent of competition for 75N95021P00090 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award